A crop of anti-pain meds rigged to thwart abuse

While anti-pain drugs are a multibillion-dollar business for pharmaceutical firms, some of the treatments such as oxycodone have been abused. This has created a market for technologies that are intended to prevent people from tampering with such pain meds for recreational use--or abuse. Seeking Alpha recently took a deep dive into several approved or late-stage anti-pain meds that feature systems to prevent abuse, with overviews of drug developers such as Acura Pharmaceuticals ($ACUR), Durrect ($DRRX), and Pfizer's ($PFE) King Pharmaceuticals. Story

Suggested Articles

Armed with microrobots and magnetic fields, Pursue scientists are looking to the future of targeted drug delivery, starting with the colon.

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.